GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV. The study, dubbed...
Read moreetectRx “It Already Does That”
Inspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It Already Does That” highlighting our FDA cleared ID-Cap™ System. We are...
Read moreA Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study
In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared ID-Cap System that positions patients for success with our technology and...
Read moreThe ID-Cap™ System: A Physician’s Perspective
“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite easily and be engaged with the system.” – Dr. Jose Castillo-Mancilla, MD, Physician and Clinical...
Read moreHigh Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic
COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if...
Read moreDigital Pill Study Shows Significant Impact on Hepatitis C Treatment Adherence and Efficacy
A study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine program (DMP) on medication adherence (Proteus Digital Health) in a population at risk for...
Read moreetectRx Targets Mental Health Field In Partnership With Local Health Pharmacy
GAINESVILLE, Fla. (February 26, 2021) – Digital health company, etectRx, Inc., announced a signed letter of intent for a novel partnership with Local Health, Inc., a subsidiary of OneroRx, a leader in operating telepharmacies and community retail...
Read moreDigital Pill Company etectRx Selects Biotech Leader as VP of Product Management
GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx...
Read moreFailure Risk in Clinical Trials? An Easy-to-Swallow Solution
Our CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial failure, and with growing remote...
Read moreetectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics
GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space...
Read moreLong-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings
Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study...
Read moreBetter Connections with Patients Using Data from Digital Pills
etectRx hosted an Xtalks Webinar on December 3: “Better Connections with Patients Using Data from Digital Pills.” Susan Baumgartner, VP of Product Management and Regulatory Affairs at etectRx, started the discussion speaking about medication...
Read more